MD, PhD, Professor Emeritus Mika Scheinin - UTU Research Portal

Mika Scheinin
MD, PhD, Professor Emeritus

Institute of Biomedicine (Faculty of Medicine)

mschein@utu.fi

: https://orcid.org/0000-0001-7579-9126

Bioanalytics; Clinical Pharmacology; Drug Development; Positron Emission Tomography; Research Ethics

13 of 13

Identification of a novel 12-nucleotide insertion polymorphism in the promoter region of ADRA2B: full linkage with the 9-nucleotide deletion in the coding region and influence on transcriptional activity (2010)
- Biochemical Pharmacology
Crassous P A, Blaise R, Marquette A, Snapir A, Scheinin M, Paris H, Schaak S
Octopamine receptors from the barnacle Balanus improvisus are activated by the α2-adrenoceptor agonist medetomidine (2010)
- Molecular Pharmacology
Lind U, Rosenblad M, Frank L, Falkbring S, Brive L, Laurila L M, Pohjanoksa K, Vuorenpää A, Kukkonen J, Gunnarsson L, Scheinin M, Mårtensson Lindblad L, Blomberg A
alpha(2A)-adrenoceptor antagonism increases insulin secretion and synergistically augments the insulinotropic effect of glibenclamide in mice (2008)
- British Journal of Pharmacology
Fagerholm V, Scheinin M, Haaparanta M
Uneven cellular expression of recombinant alpha(2A)-adrenoceptors in transfected CHO cells resultsin loss of response in adenylyl cyclase inhibition (2005)
- BBA - Molecular Cell Research
Bjork S, Vainio M, Scheinin M
Altered glucose homeostasis in alpha-2A adrenoceptor deficient mice - an FDG study (2004)
- European Journal of Nuclear Medicine and Molecular Imaging
Fagerholm V, Gronroos T, Marjamaki P, Viljanen T, Scheinin M, Haaparanta-Solin M
Phenoxybenzamine binding reveals the helical orientation of the third transmembrane domain of adrenergic receptors (2001)
- Journal of Biological Chemistry
Frang H, Cockcroft V, Karskela T, Scheinin M, Marjamaki A